Objective 11 C-acetate has been applied for evaluation of myocardial oxidative metabolism and can simultaneously estimate myocardial blood flow (MBF). We developed a new method using two-parameter spillover correction to estimate regional MBF (rMBF) with 11 C-acetate PET in reference to MBF derived from 15 O-H 2 O PET. The usefulness of our new approach was evaluated compared to the conventional method using one-parameter spillover correction. Methods Sixty-three subjects were examined with 11 Crone model in 20 subjects as a pilot group. One-parameter and two-parameter corrections were applied to suppress the spillover between left ventricular (LV) wall and LV cavity. Validation was set using the other 43 subjects' data. Finally, rMBFs were calculated using relational expression derived from the pilot-group data.
Introduction
11 C-acetate is a known PET tracer that is taken up by the heart, rapidly converted to acetyl CoA, and readily metabolized to CO 2 through the TCA cycle with oxidative phosphorylation [1] . K1 inflow rate of 11 C-acetate is largely dependent on myocardial blood flow (MBF) [2] . Oneparameter spillover correction is one of the commonly used techniques for estimating MBF [2, 3] . The method uses one coefficient value to eliminate the effect of spillover from the left ventricle (LV) cavity to the LV tissue. However, the regions of interest (ROIs) of the LV cavity and tissue potentially include a significant spillover from burring, and vice versa for the ROI of LV tissue and cavity. Therefore, multiple spillover corrections are needed. Here, we propose a two-parameter spillover correction model, with 2 independent coefficient values-one for the LV cavity within ROI, and one for the LV tissue of ROI. We assumed that the new two-parameter spillover correction would be more useful than conventional one-parameter spillover correction [4] . Thus, the first goal of this study was to develop a new two-parameter spillover correction method to estimate regional and global MBF with 11 C-acetate PET in reference to MBF derived from 15 O-H 2 O PET [5] . The second goal was to compare MBF measured with our new twoparameter model with that from the conventional oneparameter spillover correction model.
Materials and methods

Subjects
Sixty-three subjects who underwent 11 C-acetate PET and 15 O-H 2 O PET within a 2-week period from August 2006 to August 2012 were retrospectively included in this study. The Ethics Committee of Hokkaido University Hospital approved the study protocol.
Study protocol
The Renkin-Crone model was used to obtain the extraction fraction using the inflow rate of 11 C-acetate (K1) and the MBF from 15 O-H 2 O PET from the first 20 subjects, who served as a pilot group. To validate the formula developed from the pilot group data, MBF assessed by 11 C-acetate PET was computed using the remaining 43 subjects (Table 1) . MBF from 11 C-acetate was estimated by both one-parameter and two-parameter spillover correction, and was subsequently compared with MBF derived from 15 O-H 2 O PET.
PET imaging acquisition PET data acquisition was performed using a whole-body scanner (ECAT/EXACT HR?; Siemens/CTI, Asahi-Siemens Medical Technologies Ltd., Tokyo, Japan). All emissions and transmissions were acquired in the 2-dimensional mode, and attenuation-corrected radioactivity images were reconstructed using filtered back-projection with a Hann filter of 4-mm full-width at halfmaximum. Transmission scan was obtained with an external 68 Ge/ 68 Ga source. 11 C-acetate tracer (740 MBq) was administered intravenously for 60 s under resting conditions, and dynamic PET acquisition was performed (10 9 10, 1 9 60, 5 9 100, 3 9 180, and 2 9 300 s) [6] . 15 O-H 2 O (1,500 MB) was infused into an antecubital vein as a slow (2-min) infusion. A 20-frame dynamic PET scan, consisting of 6 9 5, 6 9 15, and 8 9 30 s frames, was acquired for 6 min [7] . Analysis of 15 O-H 2 O and 11 C-acetate Myocardial blood flow of 15 O-H 2 O was measured using a previously described method with the dedicated software [7] . Briefly, ROIs were drawn over the whole LV myocardium and within the LV cavity (Fig. 1) . The ROIs were projected onto the dynamic 15 O-H 2 O images. Arterial and myocardial tissue activity curves were derived with spillover correction, and were fitted to a single-tissue-compartment tracer kinetic model to calculate MBF at rest.
K1 from 11 C-acetate PET was measured using the same image-analysis method. A cylindrical ROI was positioned manually in the LV to obtain the time activity curve, LV(t), from the short axis images in the early phase. A whole myocardial ROI, R, was set semi-automatically to obtain C-acetate PET data. b A whole myocardial ROI was set semi-automatically to obtain the time activity curves from myocardium, R(t), using the last frame images of the dynamic 11 C-acetate data the time activity curves from the myocardium, R(t), using the last frame images of the dynamic 11 C-acetate data. Time activity curve in the arterial blood, C a (t), and in the myocardial tissue, C t (t), were estimated with consideration of these spillovers, modeled as a partial-volume mixture of arterial blood and tissue activity concentrations [4] . For the analysis of 11 C-acetate, an averaged metabolite correction of the input function was also contained using the result of Buck et al.; C a (t) = 0.91 exp(t/T 1/2 ) 9 LV(t), T1/ 2 = 5.3 min [8] [9] [10] . We used two methods of spillover correction to estimate K1 for the one-parameter and twoparameter methods. The K1 was estimated as described in the ''Appendix''. The parameter, ''a'' meant the contaminated ratio of the blood radioactivity into the myocardial ROI, and ''(1-a)'' yielded the mixed ratio of the myocardial radioactivity into the LV ROI in the conventional method. This was based on the ideal assumption that the total ratio of the distribution of blood and myocardium within the ROI is just 1.0. Our method enabled to calculate the parameter ''va'' which was free from the parameter ''a''. K1 was then converted into MBF using the RenkinCrone model [4, 11, 12] . Global LV and 3-coronaryregional MBFs (rMBFs) were calculated and validated [13] .
Statistical analysis
Data are expressed as mean ± SD. The correlation between MBF from 11 C-acetate and 15 O-H 2 O were assessed using linear regression analyses and Bland-Altman plots. Pearson's correlation coefficients were used to evaluate the concordance between the conventional oneparameter method and our two-parameter method. For both analyses, p values \0.05 were considered significant.
Results
Hemodynamic data at the scan
The hemodynamic data of 8 participants in the pilot group, and 4 participants in the validation group were lost. The hemodynamic data of the remaining subjects are presented in Table 2 . There were no significant differences in any of the hemodynamic data, including heart rate (HR), systolic blood pressure (sBP), diastolic blood pressure (dBP), and rate pressure product (RPP).
Pilot group
The Renkin-Crone's formula yielded the relationship between K1 from 11 C-acetate and MBF from 15 O-H 2 O PET in the whole myocardium from the pilot group. Equations 1 and 2 represent the Renkin-Crone's formula from the one-and two-parameter spillover models, respectively (Fig. 2) . Validation group Using Eqs. 1 and 2, MBFs were calculated from the 11 Cacetate data of the validation group. Calculated global MBFs from the one-and two-parameter models were 0.67 ± 0.28 and 0.68 ± 0.23, respectively (p = 0.39). Calculated rMBFs from the one-and two-parameter models were 0.69 ± 0.35 and 0.74 ± 0.27 mL/g/min for regional, respectively (p = 0.008). In both the global and regional MBF values, significant relationships were seen between the MBFs from 11 C-acetate and 15 O-H 2 O. In the validation set, the two-parameter model dedicated a significantly better correlation coefficient than the oneparameter method (r = 0.730 vs. 0.592, p \ 0.05) (Fig. 3) . Bland-Altman plots also presented more stable regional MBFs from the two-parameter spillover model than from the conventional one-parameter model (Fig. 4) .
Discussion
We developed a new, two-parameter spillover correction model to estimate global and regional MBF at the early phase of 11 C-acetate PET (0-5 min). The model demonstrated a better relationship between the MBF derived from both the 11 C-acetate and the 15 O-H 2 O PET than the previous one-parameter spillover model, suggesting that our model is a reliable equation for estimating MBF from 11 Cacetate PET scans.
Our method demonstrated a good relationship between K1 from 11 C-acetate and MBF from 15 O-H 2 O PET using the Renkin-Crone model, as well as other PET tracers such as 82 Rb [4] . This new two-parameter spillover correction method could suppress the spillover into the myocardium. Therefore, it might provide more precise MBF in the repeated measurement than the established method.
Some procedures were reported to measure the MBF using 11 C-acetate PET, such as net myocardial uptake of tracer [14] , two tissue compartment model [2] , and single tissue compartment model with one-parameter spillover collection [8] . And Timmer et al. [10] recommended the method using a single tissue compartment model with oneparameter spillover method with standardized correction for recirculating metabolites and with corrections for partial volume and spillover. Our model demonstrated a better relationship, suggesting that our model is a reliable O-H 2 O. Both one-and two-compartment models showed significant correction. The correlation using the twocompartment model (a) was significantly better than that using the one-compartment model (b) equation for estimating MBF from 11 C -acetate PET scans. The one-parameter spillover correction model is one of the established techniques for estimating the MBF in a nonlinear least-squares method [2, 3] ; in this model, the number of calculable variables is limited [15] . Our twoparameter model dedicated a significantly better coefficient value for linear correlation than the conventional oneparameter model. Therefore, the two-parameter spillover correction is more fitted to calculating MBF than the oneparameter method [7, 16] . In addition, our modified method is able to detect regional MBF reduction.
Klein et al. [17] reported the usefulness of the 11 Cacetate dynamic PET for evaluating MVO 2 in a clinical research study that assessed ischemic heart disease, dilated cardiomyopathy, aortic stenosis, and recipient heart after transplantation. The present study demonstrated that 11 Cacetate dynamic PET is reliably useful for estimating both MBF and MVO 2 . Quantification of MBF offers a great advantage in the evaluation of the functional severity of vascular function in patients with coronary artery disease [5, 13, [18] [19] [20] , as well as information about morphological stenosis [21, 22] . In the present study, we used 15 O-H 2 O as the ideal tracer to estimate MBF because, with an almost 100 % extraction of water, it is a freely diffusible tracer [7] . The extraction fraction of 11 C-acetate was also thought to be high enough to calculate MBF [8, 14] .
The present study had methodological limitations. The sample size was relatively small. However, smaller sample sizes used in previous physiological studies were found to have sufficient power to validate new methods [11, 23] . This study assessed MBF only at rest and not in a stress condition. Further studies are needed to evaluate MBF during stress tests. As we were focused on the utility of the two-parameter method for the estimation of MBF from 11 C-acetate PET, we did not discuss the correlation between MBF and MVO 2 . Finally, as this study was retrospective, some hemodynamic data, such as heart rate and blood pressure, were lost.
Some patients showed certain amount differences MBF between 11 C-acetate PET and 15 O-H 2 O. We have evaluated the background etiology of disease and the regional MBF in subjects who showed more than 40 % difference between MBF from 11 C-acetate PET and that from 15 O-H 2 O PET. Fifteen regions showed the large variation among MBFs including 8 LCX regions, 4 LAD regions, and 3 RCA regions. Seven regions were from PH patients, 3 from ICM patients, 3 from volunteers, 1 from DCM patient, and 1 from valvular disorder patient. Not only a particular patient, but also healthy volunteers were included. Therefore, the patient characteristics might be a little cause of the wide variation. The LCX region tended to show the large variation of MBF between 11 C-acetate and 15 O-H 2 O. Respiratory motion might lead to the error of the attenuation correction between the myocardium and lung, since the LCX region widely faced the lung field.
Conclusions
We developed a new method for estimating regional myocardial blood flow using dynamic PET with 11 C-acetate, which yielded a good correlation with MBF from 15 O-H 2 O PET. Our new, two-parameter spillover correction method produced a more robust estimation of regional MBF than the conventional one-parameter method. 
where a denoted myocardial tissue ratio in the ROI R, and (1-a) is spillover from blood into the ROI R.
where va is spillover from blood into the ROI R for the two-parameter method. Activity concentration in the LV blood cavity was modeled as a partial-volume mixture of arterial blood and myocardial tissue as Eq. 5.
where b denoted a recovery coefficient in the LV ROI, (1-b) is spillover from myocardium into blood pool, and m is the density of myocardial tissue (1.04 g/ml). Radioactivity in the LV blood pool was calculated using Eq. 5 with b = 85 % [4] . The change in tissue activity concentration was modeled using the one-tissue compartment model as Eq. 6.
where K1 (mL/g/min) is the uptake rate from blood into the tissue and k2 (/min) is the washout rate from myocardial tissue into the blood C a (t) (Bq/mL). The parameters K1, k2, a and va were estimated by the non-linear least-squares method using Eqs. 3, 5, and 6 for the one-parameter method and Eqs. 4, 5, and 6 for the two-parameter method. Estimated data and the curve R(t) dedicated the spillovercorrected pure blood curve C a (t).
